Stay updated on Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial
Sign up to get notified when there's something new on the Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial page.

Latest updates to the Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision updated from v3.4.1 to v3.4.2; this is a minor update that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision log updated to v3.4.1 (replacing v3.4.0). The update is metadata-only and does not change study details or user-facing information.SummaryDifference0.1%

- Check27 days agoChange DetectedIntroduced a glossary toggle and updated page metadata, including the 'Last Update Submitted that Met QC Criteria' label and the 'Revision: v3.4.0' entry (replacing the previous lowercase variant and older revision). The 'No FEAR Act Data' capitalization was standardized.SummaryDifference0.2%

- Check42 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a dedicated 'Locations' section with Alabama as the study site and updated the page revision to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedThe page now lists Revision: v3.3.2, replacing the previous Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial page.